Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Academic Institution
No.
Sign in or Register to read more
14494
Related Questions
How would you approach SCC of unknown primary, p16-, EBV-, metastatic to a large 5.5 cm level 2 neck node, if you suspect a cutaneous origin after clinical workup?
How would you approach an early stage p16+ SCC of the tonsil s/p TORS and neck dissection with initial positive margins but then negative on re-resection?
What is the recommended treatment approach for stage III/IVA nasopharyngeal cancer that is p16 negative and EBV positive?
How would you approach patients with high risk mucoepidermoid carcinoma (high grade) of the parotid gland for optimal adjuvant treatment?
How would you manage a presumed radiation induced sarcoma of the head and neck?
When would you consider larynx preservation in patients with T4N+ SCC of the larynx?
Would you consider 50 Gy in 20 fractions for a primary head and neck malignancy in an elderly patient with poor KPS?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
How would you best manage C-spine osteoradionecrosis?
What changes do you make in the management of non-endemic nasopharynx cancer compared to endemic?